Rachel K. King Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Rachel K. King.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Rachel K. King. Rachel K. King is Director in NOVAVAX INC ($NVAX) and President, CEO in GLYCOMIMETICS INC ($GLYC).

Latest Insider Trading Transactions of Rachel K. King

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, GLYC, NVAX

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 22 2021GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOOption ExerciseA3.81192,500733,425192,500
Jan 22 2021GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOGrantA0.0096,2500452,314356.1 K to 452.3 K (+27.03 %)
Dec 30 2020GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOOption ExerciseM1.12130,821146,5200
Dec 30 2020GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOSellS3.9184,176329,128356,064440.2 K to 356.1 K (-19.12 %)
Dec 30 2020GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOBuyM1.12130,821146,520440,240309.4 K to 440.2 K (+42.28 %)
Jun 26 2020NVAXNOVAVAX INCKing Rachel K.DirectorOption ExerciseA0.003,45003,450
Jun 26 2020NVAXNOVAVAX INCKing Rachel K.DirectorOption ExerciseA83.546,900576,4266,900
Jun 26 2020NVAXNOVAVAX INCKing Rachel K.DirectorOption ExerciseA0.003,45003,450
Jun 26 2020NVAXNOVAVAX INCKing Rachel K.DirectorOption ExerciseA83.546,900576,4266,900
Jan 24 2020GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOOption ExerciseA4.72349,0001,647,280349,000
Dec 16 2019NVAXNOVAVAX INCKing Rachel K.DirectorOption ExerciseA3.9918,00071,82018,000
Aug 07 2019GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOOption ExerciseM1.12166,759186,770130,821
Aug 07 2019GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOBuyM1.12166,759186,770307,144140.4 K to 307.1 K (+118.79 %)
Mar 28 2019NVAXNOVAVAX INCKing Rachel K.DirectorBuyP0.5322,00011,65622,0000 to 22 K
Mar 28 2019NVAXNOVAVAX INCKing Rachel K.DirectorBuyP0.5322,00011,65622,0000 to 22 K
Mar 28 2019NVAXNOVAVAX INCKing Rachel K.DirectorBuyP0.5342,00022,25242,0000 to 42 K
Jan 22 2019GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOOption ExerciseA10.59265,0002,806,350265,000
Nov 02 2018NVAXNOVAVAX INCKing Rachel K.DirectorOption ExerciseA1.76160,000281,600160,000
Jan 12 2018GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOOption ExerciseA20.03175,0003,505,250175,000
Jan 05 2017GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOOption ExerciseA6.33175,0001,107,750175,000
Jan 11 2016GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOOption ExerciseA5.22141,000736,020141,000
Feb 26 2015GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOOption ExerciseM1.1250,00056,000297,580
Feb 26 2015GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOBuyM1.1250,00056,000167,206117.2 K to 167.2 K (+42.66 %)
Jan 12 2015GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOOption ExerciseA7.15141,0001,008,150141,000
Jun 20 2014GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOOption ExerciseM1.12100,000112,000347,580
Jun 20 2014GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOBuyM1.12100,000112,000108,7068.7 K to 108.7 K (+1,148.63 %)
Jan 13 2014GLYCGLYCOMIMETICS INCKing Rachel K.President, CEOOption ExerciseA8.00375,6393,005,112375,639

Page:   1

Contact us | Follow us on Twitter